Holmen Aktiebolag financials
Holmen Aktiebolag
Country: SE Reporting currency: SEK Latest annual report: 2024-12-31
LEI:
52990080SH3454F0QE68 Financial statements
(SEK, as reported — unscaled; 113 line items across 2 annual periods)
| Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | SEK 22.76B | SEK 22.80B |
| Other income | SEK 2.08B | SEK 2.00B |
| Employee benefits expense | SEK 3.39B | SEK 3.31B |
| Raw materials & consumables used | SEK 12.75B | SEK 11.16B |
| Depreciation & amortisation | SEK 1.39B | SEK 1.36B |
| Operating profit (EBIT) | SEK 3.72B | SEK 4.75B |
| Net finance income / (cost) | -SEK 62.0M | -SEK 49.0M |
| Finance costs | SEK 101.0M | SEK 98.0M |
| Profit before tax | SEK 3.66B | SEK 4.71B |
| Income tax expense | SEK 798.0M | SEK 1.01B |
| Profit for the year | SEK 2.86B | SEK 3.70B |
| — attributable to owners | SEK 2.86B | SEK 3.70B |
| Total comprehensive income | SEK 2.90B | SEK 3.67B |
| Per share | ||
| Basic EPS | SEK 18.00 | SEK 23.00 |
| Diluted EPS | SEK 18.00 | SEK 23.00 |
| Free cash flow / share | SEK 8.57 | SEK 26.84 |
| Cash flow statement | ||
| Net cash from operating activities | SEK 3.32B | SEK 5.80B |
| Net cash from investing activities | -SEK 2.07B | -SEK 1.65B |
| Purchase of PP&E (capex) | SEK 1.96B | SEK 1.50B |
| Purchase of intangibles | SEK 1.0M | SEK 46.0M |
| Net cash from financing activities | -SEK 2.22B | -SEK 4.89B |
| Proceeds from borrowings | SEK 1.50B | SEK 0 |
| Lease liability payments | SEK 127.0M | SEK 114.0M |
| Net change in cash | -SEK 970.0M | -SEK 736.0M |
| Balance sheet | ||
| Total assets | SEK 81.55B | SEK 79.72B |
| Non-current assets | SEK 71.55B | SEK 69.19B |
| Property, plant & equipment | SEK 11.23B | SEK 10.33B |
| Right-of-use assets | SEK 220.0M | SEK 244.0M |
| Intangible assets & goodwill | SEK 498.0M | SEK 513.0M |
| Current assets | SEK 10.00B | SEK 10.53B |
| Inventories | SEK 5.70B | SEK 4.84B |
| Trade & other receivables | SEK 2.82B | SEK 2.70B |
| Cash & equivalents | SEK 234.0M | SEK 1.20B |
| Total equity | SEK 57.37B | SEK 56.92B |
| — attributable to owners | SEK 57.37B | SEK 56.92B |
| Non-current liabilities | SEK 17.29B | SEK 16.35B |
| Lease liabilities (non-current) | SEK 132.0M | SEK 160.0M |
| Current liabilities | SEK 6.89B | SEK 6.45B |
| Lease liabilities (current) | SEK 95.0M | SEK 91.0M |
| Derived metrics | ||
| Free cash flow | SEK 1.36B | SEK 4.31B |
| Operating margin | 16.3% | 20.9% |
| Net margin | 12.6% | 16.2% |
| Return on equity | 5.0% | 6.5% |
| Cash conversion ratio | 1.16× | 1.57× |
| Capex coverage | 1.70× | 3.88× |
| Other reported items | ||
| Additional Paidin Capital | SEK 281.0M | SEK 281.0M |
| Adjusted Weighted Average Shares | 158.8M | 160.5M |
| Adjustments For Amounts Transferred To Initial Carrying Amount of Hedged Items | SEK 0 | SEK 6.0M |
| Adjustments For Decrease Increase In Inventories | -SEK 824.0M | SEK 11.0M |
| Adjustments For Decrease Increase In Trade and Other Receivables | SEK 4.0M | SEK 899.0M |
| Adjustments For Depreciation and Amortisation Expense | SEK 1.39B | SEK 1.36B |
| Adjustments For Gains Losses On Change In Fair Value Less Costs To Sell Biological Assets | SEK 907.0M | SEK 562.0M |
| Adjustments For Increase Decrease In Trade and Other Payables | SEK 409.0M | -SEK 417.0M |
| Adjustments For Provisions | -SEK 16.0M | -SEK 12.0M |
| Amount Removed From Reserve of Cash Flow Hedges and Included In Initial Cost Or Other Carrying Amount of Nonfinancial Asset Liability Or Firm Commitment For Which Fair Value Hedge Accounting Is Applied | -SEK 16.0M | — |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | SEK 0 | SEK 0 |
| Cash Flows From Used In Operations Before Changes In Working Capital | SEK 3.73B | SEK 5.31B |
| Changes In Inventories of Finished Goods and Work In Progress | -SEK 233.0M | SEK 79.0M |
| Comprehensive Income Attributable To Owners of Parent | SEK 2.90B | SEK 3.67B |
| Current Tax Assets Current | SEK 144.0M | SEK 114.0M |
| Current Tax Liabilities Current | SEK 97.0M | SEK 105.0M |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | SEK 1.83B | SEK 2.59B |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners | SEK 1.89B | — |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | SEK 12.00 | — |
| Dividends Recognised As Distributions To Owners of Parent | SEK 1.83B | SEK 2.59B |
| Dividends Recognised As Distributions To Owners Per Share | SEK 11.50 | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | SEK 2.0M | SEK 3.0M |
| Equity and Liabilities | SEK 81.55B | SEK 79.72B |
| Finance Income | SEK 39.0M | SEK 49.0M |
| Gains Losses On Cash Flow Hedges Before Tax | -SEK 95.0M | -SEK 815.0M |
| Gains Losses On Exchange Differences On Translation Before Tax | SEK 181.0M | SEK 55.0M |
| Gains Losses On Hedges of Net Investments In Foreign Operations Before Tax | -SEK 127.0M | -SEK 42.0M |
| Income Tax Relating To Components of Other Comprehensive Income | SEK 37.0M | SEK 22.0M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss | -SEK 129.0M | -SEK 740.0M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | SEK 92.0M | SEK 718.0M |
| Income Taxes Paid Refund Classified As Operating Activities | SEK 425.0M | SEK 160.0M |
| Increase Decrease Through Sharebased Payment Transactions | SEK 11.0M | SEK 13.0M |
| Investment Accounted For Using Equity Method | SEK 1.70B | SEK 1.69B |
| Issued Capital | SEK 4.24B | SEK 4.24B |
| Liabilities | SEK 24.18B | SEK 22.80B |
| Net Deferred Tax Assets | SEK 3.0M | SEK 3.0M |
| Net Deferred Tax Liabilities | SEK 14.25B | SEK 13.86B |
| Noncurrent Biological Assets | SEK 31.60B | SEK 30.55B |
| Noncurrent Financial Assets At Amortised Cost | SEK 6.0M | SEK 5.0M |
| Noncurrent Recognised Liabilities Defined Benefit Plan | SEK 9.0M | SEK 9.0M |
| Other Adjustments For Noncash Items | SEK 28.0M | -SEK 19.0M |
| Other Comprehensive Income | SEK 39.0M | -SEK 27.0M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | -SEK 5.0M | -SEK 6.0M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -SEK 318.0M | -SEK 2.79B |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | SEK 357.0M | SEK 2.77B |
| Other Current Financial Assets | SEK 15.0M | SEK 50.0M |
| Other Current Financial Liabilities | SEK 953.0M | SEK 1.02B |
| Other Current Liabilities | SEK 1.90B | SEK 1.81B |
| Other Current Receivables | SEK 1.08B | SEK 1.63B |
| Other Expense By Nature | SEK 4.74B | SEK 4.69B |
| Other Inflows Outflows of Cash Classified As Financing Activities | -SEK 3.0M | SEK 0 |
| Other Longterm Provisions | SEK 389.0M | SEK 418.0M |
| Other Noncurrent Financial Assets | SEK 46.0M | SEK 61.0M |
| Other Noncurrent Financial Liabilities | SEK 2.50B | SEK 1.90B |
| Other Reserves | SEK 20.73B | SEK 20.67B |
| Other Shortterm Provisions | SEK 45.0M | SEK 31.0M |
| Payments To Acquire Or Redeem Entitys Shares | SEK 647.0M | SEK 1.12B |
| Proceeds From Sales of Biological Assets | SEK 20.0M | SEK 38.0M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | SEK 38.0M | SEK 15.0M |
| Purchase of Biological Assets | SEK 158.0M | SEK 162.0M |
| Purchase of Treasury Shares | SEK 647.0M | SEK 1.12B |
| Reclassification Adjustments On Cash Flow Hedges Before Tax | SEK 406.0M | SEK 2.73B |
| Repayments of Current Borrowings | SEK 112.0M | SEK 64.0M |
| Repayments of Noncurrent Borrowings | SEK 1.00B | SEK 1.00B |
| Retained Earnings | SEK 32.13B | SEK 31.74B |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | SEK 7.0M | SEK 6.0M |
| Trade and Other Current Payables To Trade Suppliers | SEK 3.81B | SEK 3.39B |
| Weighted Average Shares | 158.8M | 160.5M |
Methodology
Every line item above is a fact tagged in Holmen Aktiebolag's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (SEK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.